Prestige Consumer Healthcare (NYSE:PBH) Posts Quarterly Earnings Results, Misses Estimates By $0.12 EPS

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $1.02 EPS for the quarter, missing the consensus estimate of $1.14 by ($0.12), Briefing.com reports. The firm had revenue of $277.00 million for the quarter, compared to analysts' expectations of $287.42 million. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. Prestige Consumer Healthcare's revenue was down 3.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.07 EPS. Prestige Consumer Healthcare updated its FY 2025 guidance to 4.400-4.460 EPS and its FY25 guidance to $4.40-$4.46 EPS.

Prestige Consumer Healthcare Stock Down 7.0 %

NYSE:PBH traded down $5.01 on Wednesday, reaching $66.46. 824,453 shares of the stock traded hands, compared to its average volume of 239,073. The company's fifty day simple moving average is $71.12 and its 200 day simple moving average is $65.18. Prestige Consumer Healthcare has a 12 month low of $55.96 and a 12 month high of $75.31. The company has a current ratio of 3.09, a quick ratio of 1.92 and a debt-to-equity ratio of 0.75. The company has a market capitalization of $3.30 billion, a price-to-earnings ratio of -40.86, a PEG ratio of 1.91 and a beta of 0.53.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on PBH shares. StockNews.com raised shares of Prestige Consumer Healthcare from a "buy" rating to a "strong-buy" rating in a research note on Monday. TheStreet raised Prestige Consumer Healthcare from a "c+" rating to a "b-" rating in a research note on Monday, February 12th. One equities research analyst has rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $110.00.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.